Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 68 pseudogene (ENSG00000270555) is a non-protein-coding segment of the human genome related to the TMEM68 gene, resulting from genomic duplication or retrotransposition events that have rendered it incapable of coding a functional protein. Pseudogenes like this one typically contain disabling mutations or lack regulatory elements required for gene expression and protein synthesis. While traditionally considered "junk DNA," some pseudogenes can be transcribed and participate in gene regulatory networks, for example by acting as decoys for microRNAs or through other regulatory mechanisms, but there is no direct evidence that this particular pseudogene functions as a therapeutic target or codes for an active receptor, enzyme, or transporter[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 68 pseudogene.